The combined database will allow scientists to
puzzle out the genetic components
of relatively rare conditions — such as Parkinson's disease or
specific types of cancer — that affect only 1 % to 5 %
of the population, comments behavioral geneticist Matthew McGue
of the University
of Minnesota, Twin Cities, who is not directly involved in the consortium.